Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study of metastasis

09.07.2004


Metastasis of cancer may cause as many, if not more, deaths than cancer itself. Amongst other reasons, this is because it is very difficult to know where the new tumour is going to develop. Moreover, the mechanisms of metastasis are still not well understood, although a lot of research into it is taking place and advances are being made. Dominion Pharmakine is a company located at the Bizkaia Technological Park where they are studying metastasis.




At times, a cell in our body may suffer a mutation and starts to multiply in an uncontrolled manner. All the cells thus formed result in a tumour which interferes in the form and functions of the tissue of which it is part. Moreover, the tumour provokes the creation of new blood vessels, which assures a good food supply.

If the tumour limits itself to growing, it is said to be a benign tumour and, in most cases, does not require treatment. But, if malignant, it must be treated. If not extirpated, pharmaceutical drugs have to be used to combat the tumour. But the tumour usually has a number of defence mechanisms. One of these is a proteic layer difficult to penetrate by some of these drugs. Dominion Pharmakine is studying which these area and also the suitability of the molecular targets used by the new drugs for bonding to the pathological cells, i.e. they are trying to identify the molecule that best offers the possibility of penetration of the unhealthy cell.


But unfortunately, malign tumours, apart from growing, may spread throughout the body, i.e. they may produce a metastasis. Some of the cells separate from the tumour and are carried to other parts of the body through the blood system, via the newly-formed vessels. Once in the blood system, it is distributed through the whole body until they attach themselves to some new tissue and initiate a new tumour.

Metastasis initiates as a consequence of two changes in the genetic expression and protein synthesis that occur in the initial tumour. Dominion Pharmakine is also investigating the relationship between this genetic expression and metastasis. From this information, two objectives are sought: on the one hand, predicting the evolution of the tumour using the genetic expression arising and, on the other, designing new specific drugs based on this expression.

The Dominion Pharmakine company was formed as a spin off of the Faculty of Medicine at the University of the Basque Country.

Eneko Imaz | Basque Research
Further information:
http://www.pharmakine.com
http://www.elhuyar.com

More articles from Life Sciences:

nachricht Elucidating cuttlefish camouflage
18.10.2018 | Max-Planck-Institut für Hirnforschung

nachricht Sensory Perception Is Not a One-Way Street
17.10.2018 | Eberhard Karls Universität Tübingen

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Goodbye, silicon? On the way to new electronic materials with metal-organic networks

Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz (Germany) together with scientists from Dresden, Leipzig, Sofia (Bulgaria) and Madrid (Spain) have now developed and characterized a novel, metal-organic material which displays electrical properties mimicking those of highly crystalline silicon. The material which can easily be fabricated at room temperature could serve as a replacement for expensive conventional inorganic materials used in optoelectronics.

Silicon, a so called semiconductor, is currently widely employed for the development of components such as solar cells, LEDs or computer chips. High purity...

Im Focus: Storage & Transport of highly volatile Gases made safer & cheaper by the use of “Kinetic Trapping"

Augsburg chemists present a new technology for compressing, storing and transporting highly volatile gases in porous frameworks/New prospects for gas-powered vehicles

Storage of highly volatile gases has always been a major technological challenge, not least for use in the automotive sector, for, for example, methane or...

Im Focus: Disrupting crystalline order to restore superfluidity

When we put water in a freezer, water molecules crystallize and form ice. This change from one phase of matter to another is called a phase transition. While this transition, and countless others that occur in nature, typically takes place at the same fixed conditions, such as the freezing point, one can ask how it can be influenced in a controlled way.

We are all familiar with such control of the freezing transition, as it is an essential ingredient in the art of making a sorbet or a slushy. To make a cold...

Im Focus: Micro energy harvesters for the Internet of Things

Fraunhofer IWS Dresden scientists print electronic layers with polymer ink

Thin organic layers provide machines and equipment with new functions. They enable, for example, tiny energy recuperators. In future, these will be installed...

Im Focus: Dynamik einzelner Proteine

Neue Messmethode erlaubt es Forschenden, die Bewegung von Molekülen lange und genau zu verfolgen

Das Zusammenspiel aus Struktur und Dynamik bestimmt die Funktion von Proteinen, den molekularen Werkzeugen der Zelle. Durch Fortschritte in der...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Conference to pave the way for new therapies

17.10.2018 | Event News

Berlin5GWeek: Private industrial networks and temporary 5G connectivity islands

16.10.2018 | Event News

5th International Conference on Cellular Materials (CellMAT), Scientific Programme online

02.10.2018 | Event News

 
Latest News

Elucidating cuttlefish camouflage

18.10.2018 | Life Sciences

Robot-assisted sensor system for quality assurance of press-hardened components

17.10.2018 | Trade Fair News

Sensory Perception Is Not a One-Way Street

17.10.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>